1022P A phase II trial of the IO102-IO103 vaccine plus pembrolizumab: Completed cohort for first-line (1L) treatment of advanced squamous cell carcinoma of the head and neck (SCCHN)Jonathan W. Riess, V. Villaflor, J. Rubio Perez et al.|Annals of Oncology|2024Cited by 3
77P Experience pooling control arms within a complex phase I drug-radiotherapy (RT) platform trialJamie B. Oughton, Sarah Brown, J. Kendall et al.|ESMO Open|2024Cited by 0